KYOTO PHARMA IND has a total of 417 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 1965. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are AVEXA LTD, DELAGRANGE LAB and EHJSAJ AR EHND DI MENEDZHMENT KO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 123 | |
#2 | WIPO (World Intellectual Property Organization) | 41 | |
#3 | EPO (European Patent Office) | 31 | |
#4 | United States | 29 | |
#5 | Australia | 27 | |
#6 | Canada | 23 | |
#7 | Norway | 11 | |
#8 | New Zealand | 10 | |
#9 | Brazil | 9 | |
#10 | China | 8 | |
#11 | South Africa | 8 | |
#12 | Denmark | 7 | |
#13 | Spain | 7 | |
#14 | Israel | 7 | |
#15 | Taiwan | 7 | |
#16 | Argentina | 6 | |
#17 | Colombia | 6 | |
#18 | Hong Kong | 6 | |
#19 | Yugoslavia (Serbia and Montenegro) | 6 | |
#20 | Hungary | 5 | |
#21 | Republic of Korea | 5 | |
#22 | Mexico | 5 | |
#23 | Finland | 3 | |
#24 | France | 3 | |
#25 | United Kingdom | 3 | |
#26 | Italy | 3 | |
#27 | USSR (Union of Socialist Soviet Republics) | 3 | |
#28 | Bulgaria | 2 | |
#29 | Germany | 2 | |
#30 | Indonesia | 2 | |
#31 | Slovakia | 2 | |
#32 | Belgium | 1 | |
#33 | Switzerland | 1 | |
#34 | Cyprus | 1 | |
#35 | Greece | 1 | |
#36 | Portugal | 1 | |
#37 | Serbia | 1 | |
#38 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Transport |
# | Name | Total Patents |
---|---|---|
#1 | Matsui Hiroshi | 128 |
#2 | Shirahase Hiroaki | 109 |
#3 | Kasai Masayasu | 98 |
#4 | Kitao Kazuhiko | 93 |
#5 | Yoshimi Akihisa | 81 |
#6 | Nishizawa Susumu | 68 |
#7 | Kakeya Nobuharu | 58 |
#8 | Kakeya Senji | 57 |
#9 | Tamaki Satoshi | 47 |
#10 | Azukizawa Satoru | 40 |
Publication | Filing date | Title |
---|---|---|
WO2020105701A1 | Novel polymer-active drug conjugate and use thereof | |
WO2020071550A1 | Cdk8 inhibitor and use of same | |
WO2020013116A1 | Ptp-1b inhibitor and use thereof | |
WO2019225625A1 | Readthrough inducer and pharmaceutical use thereof | |
WO2019103050A1 | Protein-binding drug | |
EP3607944A1 | Novel cyclin-dependent kinase 8 and/or 19 inhibitor | |
JP2020100564A | Read-through inducer and pharmaceutical use thereof | |
JP2016193894A | Viable cell-containing preparation | |
JP2016193893A | Viable cell preparation | |
CA2951627A1 | Novel anticancer agent | |
US2016207883A1 | Aromatic compound and use thereof | |
WO2014123203A1 | Therapeutic agent for diabetes | |
WO2012033195A1 | Heterocyclic compound | |
JP2012239648A | Blister package body | |
JP2012036140A | Rapid disintegrating tablet with reduced bitterness | |
JP2010270040A | Orally disintegrating tablet | |
JP2010164415A | Apparatus and method for testing disintegration of tablet | |
JP2010070466A | Disintegrating tablet in oral cavity | |
JP2008260778A | Film-coated tablet | |
JP2008094837A | Masking for bitter taste |